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Preliminary Investigation of the Area Under the L-Lactate
Concentration–Time Curve (LACAREA) in Critically Ill Equine
Neonates
P.A. Wilkins, B.J. Sheahan, K.A. Vander Werf, C. Castagnetti, J. Hardy, A. Schoster, and R.C. Boston
Background: A variety of measures of L-lactate concentration ([LAC]) in the blood of critically ill neonatal foals have
shown utility as prognostic indicators. These measures, evaluating either the severity of hyperlactatemia or the duration of
exposure to hyperlactatemia, perform fairly well and have correctly classiﬁed 75–80% of foals examined in several studies.
The area under the L-lactate concentration versus time curve (LACArea) encompasses both severity and duration of hyperlac-
tatemia and should improve correct classiﬁcation of patient survival.
Hypothesis/Objectives: LACArea is larger in nonsurviving critically ill neonatal foals.
Animals: Forty-nine foals admitted for critical illness to 1 of 4 referral hospitals.
Methods: Whole blood was obtained at admission and 6, 12, 18, and 24 hours after admission for measurement of
L-lactate using a handheld lactate meter. LACArea was calculated for: admission–6, 6–12, 12–18, 18–24 hours, and admis-
sion–24 hours using the trapezoidal method and summing the 6-hours interval areas to determine total 24 hours area.
Diﬀerences between survivors and nonsurvivors were determined using robust regression and Kruskal–Wallis testing,
P < .05.
Results: LACArea was signiﬁcantly larger in nonsurviving foals (n = 9) than in surviving foals (n = 40) at all time periods
examined.
Conclusions and Clinical Importance: Diﬀerences in LACArea between surviving and nonsurviving critically ill neonatal
foals are large and support further investigation of this method as an improved biomarker for survival in critically ill neona-
tal foals is indicated.
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Lactate (LAC) is a normal metabolite present in theblood of neonatal foals. Abnormally increased L-
lactate concentration is a fairly reliable biomarker of
disease severity and outcome in critically ill foals, cor-
rectly classifying survival to hospital discharge in
approximately 75–80% of cases.1–5 Increased LAC con-
centration at admission ([LAC]Admit) evaluates the
severity or magnitude of initial hyperlactatemia,
whereas the change in [LAC] with time ([LAC]Δ) evalu-
ates the duration or persistence of initial hyperlactatemia
in the face of treatment. Both, when abnormal, are asso-
ciated with decreased survival to hospital discharge in ill
neonatal foals.1–5 Although initial hyperlactatemia
([LAC]Admit) commonly is caused by poor oxygen deliv-
ery to tissues, persistent hyperlactatemia ([LAC]Δ) has
been associated with dysmetabolism and poor oxygen uti-
lization by tissues in the face of adequate oxygen deliv-
ery.1,2 This report evaluates the magnitude of the area
under the 24-hour [LAC] versus time curve (LACArea), a
unique measure of [LAC] exposure that evaluates both
severity and duration of hyperlactatemia, in critically ill
neonatal foals. This report also provides a preliminary
analysis of diﬀerences in LACArea between surviving and
nonsurviving treated foals.
Materials and Methods
Animals
Neonatal foals <30 days of age presenting to 1 of 4 university
or private referral hospitals in 2014 for treatment of conditions
requiring intensive or critical care were studied after client
informed consent. The study protocol was approved by the Uni-
versity of Illinois Institutional Animal Care and Use Committee
(IACUC approval no. 13149).
From the Department of Veterinary Clinical Medicine, College of
Veterinary Medicine, University of Illinois, Urbana, IL (Wilkins,
Sheahan, Vander Werf); the Department of Veterinary Medical
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Department of Large Animal Clinical Sciences, College of
Veterinary Medicine & Biomedical Sciences, Texas A & M
University, College Station, TX (Hardy); the Vetsuisse Faculty,
University of Zurich, Zurich, Switzerland (Schoster); and the
Department of Clinical Studies, New Bolton Center, University of
Pennsylvania School of Veterinary Medicine, Kennett Square, PA
(Boston).
Data were collected for this study at the University of Illinois
CVM, University of Bologna, Texas A & M CVM, University of
Zurich.
The results of this study have not been presented at any scientiﬁc
meeting as of the time of manuscript submission.
Corresponding author: P.A. Wilkins, Department of Veterinary
Clinical Medicine, College of Veterinary Medicine, University of
Illinois, 1008 West Hazelwood Drive, Urbana, IL 1082;
e-mail: pawilkin@illinois.edu.
Submitted October 31, 2014; Revised December 13, 2014;
Accepted January 20, 2015.
Copyright © 2015 The Authors. Journal of Veterinary Internal
Medicine published by Wiley Periodicals, Inc. on behalf of the Ameri-
can College of Veterinary Internal Medicine.
This is an open access article under the terms of the Creative
Commons Attribution-NonCommercial License, which permits use,
distribution and reproduction in any medium, provided the original
work is properly cited and is not used for commercial purposes.
DOI: 10.1111/jvim.12559
Abbreviations:
LAC lactate
[LAC] lactate concentration
[LAC]Admit lactate concentration at admission
[LAC]D lactate concentration change over time
LACArea area under [LAC] versus time curve
J Vet Intern Med 2015;29:659–662
Sampling Protocol
Whole blood (0.5–1 mL) was obtained by either direct veni-
puncture of a jugular vein using a preheparinized syringe or via
aseptically placed IV catheter at admission. Catheter samples were
obtained after removing a volume of blood equal to at least 39
the dead space volume of the catheter and associated extension
sets. This presample of blood was returned to the patient via the
IV catheter. Additional samples were similarly obtained at 6, 12,
18, and 24 hours after the initial sample.
L-Lactate Measurement, Calculation of LACArea, and
Determination of Outcome to Hospital Discharge
[LAC] was determined using the [LAC] measuring techniques
currently in use at each participating hospital. LACArea was deter-
mined using samples obtained over the ﬁrst 24 hours of hospital-
ization at 6 hours intervals by the trapezoidal method for
numerical integration.6 The trapezoidal method allows for calcula-
tion of larger areas under curves by reduction and calculation of
smaller areas under the curve. This is accomplished by using the
formula for calculating the area of a trapezoid and summing those
areas (Fig 1). Short-term outcome was deﬁned as survival or non-
survival to hospital discharge and was recorded by the participat-
ing clinician at each hospital.
Statistical Analysis
Data were tested for normality using the Shapiro–Wilk method.
If not normally distributed, data were log transformed. Diﬀerences
between surviving and nonsurviving foals were tested using Krus-
kal–Wallis and robust regression methods, P ≤ .05.
Results
Forty-nine foals were enrolled in the study. The aver-
age  SD age at admission was 36.9  49.4 hours
(median 29 hours; range, 0–264 hours). No statistical
diﬀerence was noted between foals that survived and
those that did not. Four foals did not survive the entire
24 hours of initial hospitalization; an additional 5 foals
did not survive to hospital discharge. Primary clinical
diagnoses determined by the primary attending clinician
were: perinatal asphyxia syndrome (11); sepsis (11);
diarrhea (8); failure of passive transfer (7); meconium
impaction (7); and prematurity, dystocia, ﬂexural defor-
mity, and trauma and premature placental separation
(“red bag delivery”), 1 each. Secondary clinical diagno-
ses included: sepsis (10); failure of passive transfer (10);
perinatal asphyxia syndrome (4); ﬂexural deformity (2);
and cleft palate, intussusception, trauma, prematurity,
diarrhea, and ocular problem, 1 each.
Overall, data were not normally distributed (skewed)
and were log transformed for analysis. Lactate concen-
tration at all testing times are presented in Table 1.
Brieﬂy, [LAC] were diﬀerent between foals that lived
and those that died at all sampling times except admis-
sion. Regarding LACArea, based on robust regression
results, diﬀerences between foals that lived and those
that died were highly signiﬁcantly diﬀerent at all testing
periods (Table 2).
Discussion
This study shows that calculation of LACArea has
potential to be a useful indicator of prognosis in criti-
cally ill equine neonates, potentially improving ability
to predict survival over predictions based on [LAC]Admit
or measures of change in [LAC] over time.1–5,7 Area
under the [LAC] versus time curve has been applied to
human pediatric patients and shown improvement in
both sensitivity and speciﬁcity for prediction of out-
come when compared to both [LAC]Admit and [LAC]D,
likely because of its ability to evaluate not only severity
of hyperlactatemia but also duration of exposure to
hyperlactatemia during the initial therapeutic period.7
In clinically aﬀected foals, LACArea is likely to be
related to both the persistence and the severity of
increased [LAC] during the early course of treatment
(ie, it is inﬂuenced by the exposure time to hyperlactat-
emia as well as the actual L-lactate concentrations).
We did not examine increased risk of nonsurvival
associated with increased LACArea because of the rela-
tively low number of nonsurvivors in this study, which
precluded statistical analysis. Because of the low num-
ber of cases we also did not provide or perform any
analysis by primary clinical diagnosis, although this
type of analysis would be of interest.
The normal values of LACArea in equine neonates are
now known to be age-dependent and demonstrate signif-
icant decreases over the ﬁrst 3 days of life, with a smaller
yet still signiﬁcant decrease between 3 and 7–14 days
after birth.8 This age-dependent decrease in [LAC] and
LACArea over the ﬁrst few days of life may confound
evaluation of the various LAC measures as tools for
evaluating prognosis and disease severity, prematurity
also may be an important confounder.8,9,10 The fetus uti-
lizes L-lactate as an important energy source, and failure
Fig 1. Calculation of L-lactate concentration versus time area
under the curve (AUC) using the trapezoid method. The AUC ﬁrst
is calculated for each individual 6 hours interval using the formula
for the area of a trapezoid; [½ (h1 + h2)] • b, which becomes for
our purposes: [½ ([LAC]TimeX + [LAC]TimeY)] • h. Individual
AUCs are calculated for each 6-hours interval and then summed
to obtain the total AUC for 24 hours. The dashed line represents
the top of the total 24-hours AUC calculated using only Admis-
sion and 24-hours values, which would have overestimated actual
AUC by approximately 25%.
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to adapt to post-fetal energy metabolism, along with
alteration in extravascular volume, may be features of
some disease processes.9,10 Calculation and evaluation of
LACArea in studies of sick equine neonates may require
some adjustment for age-related diﬀerences; the impact
of age diﬀerences currently are unknown and were not
examined in this study.
In this study, we did not attempt to standardize the
method of LAC measurement, which may have
increased the variability in the results. We also did not
record or consider types or volumes of IV ﬂuids admin-
istered which, especially ﬂuids containing dextrose,
might have impacted LAC measurement. Finally,
participating hospitals were not provided with speciﬁc
deﬁnitions for clinical diagnosis classiﬁcation. These
limitations of the study should be considered when
designing future studies to evaluate this potentially use-
ful LAC parameter in ill neonatal foals.
Although survival-to-discharge percentages for criti-
cally ill foals have increased to approximately 80%
from a low of approximately 50–60% in the 1980s to
early 1990s, there remains room for improvement
because approximately 20% of all foals evaluated using
LAC parameters are currently misclassiﬁed regarding
Table 1. L-lactate concentrations obtained at 5 time periods: Admission, and at 6, 12, 18 and 24 hours after admis-
sion. Signiﬁcant diﬀerences were identiﬁed between foals that lived and those that died at each time period except at
admission. Some sampling times were missed for foals surviving for 24 hours; 4 foals did not survive the initial
24 hours of hospitalization and treatment, whereas 5 additional foals did not survive to hospital discharge after the
initial 24 hours of hospitalization.
Sample Time Outcome Mean  SD, mmol/L Median (Range), mmol/L n P Value
Admission All 4.9  4.6 3.2 (0.9–21.0) 49 .278
Lived 4.6  4.1 3.1 (0.9–16.9) 40
Died 6.5  6.27 4.1 (1.5–21.0) 9
6 hours All 4.8  4.8 2.4 (1.1–22.1) 47 .035
Lived 4.0  3.8 2.3 (1.1–18.5) 39
Died 8.8  73 6.9 (1.7–21.2) 8
12 hours All 3.7  3.8 2.3 (1.0–23.0) 47 .028
Lived 3.1  2.4 2.2 (1.0–11.8) 40
Died 7.3  7.2 5.1 (1.4–23.0) 7
18 hours All 3.0  2.5 2.1 (0.9–14.6) 43 .035
Lived 2.8  2.6 2.0 (0.9–14.6) 37
Died 4.3  2.2 3.9 (1.6–7.7) 6
24 hours All 2.7  2.6 1.9 (0.9–14.8) 45 .010
Lived 2.4  2.4 1.8 (0.9–14.8) 40
Died 5.0  3.0 4.5 (1.8–10) 5
Table 2. Area under the [LAC] versus time curve calculated using the trapezoid method at 5 time periods: Admis-
sion–6, 6–12, 12–18, 18–24 hours, and Admission–24 hours after hospital admission. Signiﬁcant diﬀerences were
identiﬁed between foals that lived and those that died for all sampling periods. Some sampling times were missed for
foals surviving for 24 hours; 4 foals did not survive the initial 24 hours of hospitalization and treatment, whereas 5
additional foals did not survive to hospital discharge after the initial 24 hours of hospitalization.
Sample Time Outcome Mean  SD, mmol/L* h Median (Range), mmol/L* h n P Value
Admission–6 hours All 28.9  26.1 18.3 (7.8–118.7) 47 .017
Lived 25.8  22.8 18 (7.8–89.4) 39
Died 44.1  36.5 32.1 (10.8–118.7) 8
6–12 hours All 24.5  22.2 14.6 (7.5–124.8) 46 <.001
Lived 21.2  16.6 13.8 (7.5–61.5) 39
Died 43.1  38.5 33.9 (9.9–124.8) 7
12–18 hours All 19.2  14.8 13.2 (5.7–79.2) 43 <.001
Lived 17.9  14.8 12.6 (5.7–79.2) 37
Died 27.1  13.0 27.6 (9.0–47.4) 6
18–24 hours All 17.6  15.5 11.6 (5.4–88.2) 42 <.001
Lived 16.0  15.1 11.4 (5.4–88.2) 37
Died 29.7  14.4 26.4 (14.7–53.1) 5
24 hours Total All 87.1  67.4 58.5 (27.0–276.0) 42 <.001
Lived 82.2  62.2 54 (27.0–276.0) 37
Died 122.9  44.2 122.4 (61.2–185.7) 5
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survival to discharge.1–5 Early identiﬁcation of foals at
greater risk of nonsurvival may be facilitated by use of
this easy to calculate, simple, inexpensive stall-side test,
allowing for earlier institution of life-saving monitoring,
treatment and intervention protocols. A large prospec-
tive multicenter study of this potentially useful prognos-
tic indicator is indicated.
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